Inhaled mycophenolate mofetil formulations for the prevention of lung allograft rejection
The use of lung transplantation, a life saving intervention, has been increasing over the last thirty years with a disappointing median survival of only 4.8 years. Despite the progress made in immunosuppressive therapies, allograft rejection following transplantation is the leading cause of death. A...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/ETD-UT-2012-08-5903 |